This report provides estimates of the number of laboratories performing tumor
marker assays, as well as test volume and sales forecasts by country.
The report also presents strategic analyses of leading current and emerging
suppliers of cancer diagnostic products in terms of their sales, market
shares, product portfolios, distribution tactics, technological know-how, new
products in R&D, collaborative arrangements and business strategies.
Contains 104 pages and 3 tables
Table of Contents
Table of Contents
1. Worldwide Business Environment
2. Worldwide Market Structure
3. Worldwide Market Size and Growth
4. Competitive Assessments:
Abbott
AdnaGen
Applied Gene Technologies
Arca
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
Cepheid
Correlogic Systems
Dako
Decode
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Gen-Probe
Guided Therapeutics
Hologic
Ipsogen
Kreatech
Kyowa Medex
Life Technologies
Mackay Life Sciences
Myriad Genetics
Nanogen/Elitech
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zila
List of Tables
Worldwide, All Market Segments, Laboratories Performing Cancer Diagnostic
Testing By Country
Worldwide, All Market Segments, Cancer Diagnostic Test Volume Forecasts By
Country
Worldwide, All Market Segments, Cancer Diagnostics Sales Forecasts By
Country
Analysis of the World Tumor Markers Testing Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers published by Venture Planning Group in September 12, 2012. This report price starts from US $ 3500.
